20 ML donanemab-azbt 17.5 MG/ML Injection [Kisunla]

RxNorm concept 2687979, branded drug (sbd). Prescribable name: kisunla 350 MG in 20 ML Injection.

RxCUI: 2687979
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2687979 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

donanemab 2687966

Other names

Kisunla 350 MG per 20 ML Injection

Related concepts

donanemab-azbt 17.5 MG/ML (SCDC, consists of)
donanemab-azbt 17.5 MG/ML [Kisunla] (SBDC, consists of)
Injection (DF, has dose form)
Kisunla (BN, has ingredient)
20 ML donanemab-azbt 17.5 MG/ML Injection (SCD, tradename of)

Linked data

NDCs

00002940101

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2687979 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2687979 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2687979. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.